Medicore
Acquisition in 2024
Medicore is a forward-thinking and rapidly expanding creator of unique web-based, interoperable electronic patient and client records (EHRs) and data-driven healthcare solutions.
Imagine Human
Acquisition in 2024
Imagine Human offers software, advice, and service to the quality of life at work, risk prevention, and support for HR policies.
Kayentis
Venture Round in 2023
Kayentis is a global leader in electronic clinical outcome assessment (eCOA) and Decentralized Clinical Trial solutions, focused on enhancing the efficiency and quality of data collection in clinical trials for the pharmaceutical, biotech, and contract research organization sectors. Founded in 2005, the company has specialized in eCOA solutions across various phases of clinical development, addressing over 200 indications in more than 20 therapeutic areas. Kayentis has adapted to the evolving clinical research landscape by offering a comprehensive suite of services aimed at supporting science-driven and patient-centric approaches. With operational capabilities spanning the USA, Europe, and Asia, Kayentis provides a range of adaptable tools to streamline electronic data capture, simplifying the clinical trial process for both patients and research sites.
Val Solutions
Acquisition in 2023
Val Solutions specializes in software applications focused on occupational health and the prevention of workplace risks. The company offers a comprehensive platform that supports all project stages, from initial design to final acceptance, thereby enhancing the efficiency of health professionals. By streamlining daily operations and fostering engagement among companies and employees, Val Solutions facilitates a proactive approach to health and safety in the workplace. Additionally, its solutions help professionals comply with regulatory health and safety requirements, contributing to improved wellbeing at work.
Keenturtle
Venture Round in 2021
Keenturtle is a technology company focused on developing software solutions for the healthcare sector. The company specializes in creating a clinical decision platform that identifies the risks associated with medication prescription errors in real-time, tailored to the unique needs of each patient. By preventing hospital-related complications, Keenturtle enhances patient safety and reduces the likelihood of medication-related issues. Additionally, their platform offers pharmacists personalized and contextual decision support, facilitating timely and informed decision-making by healthcare providers. Through these innovations, Keenturtle aims to improve treatment pathways and overall health outcomes in the pharmaceutical domain.
BMI System
Acquisition in 2021
BMI System Limited, incorporated in 2010 and based in London, United Kingdom, specializes in developing interactive leisure and entertainment software. The company focuses on providing management software tailored for the pharmaceutical, medical, and cosmetics industries. BMI System has established itself as a prominent player in regulatory compliance software for the pharmaceutical sector with its NAYA Compliance application, which has gained recognition as a leading solution in France. Additionally, the company exports its software packages to markets in Europe and America, expanding its reach and influence in the industry.
DigitecPharma
Venture Round in 2021
DigitecPharma is a company that specializes in developing advanced technology solutions for independent pharmacies and pharmacy groups. It offers a mobile application designed to support the evolving role of dispensary pharmacists. This innovative application, coupled with a responsive website, allows pharmacies to customize their communication strategies and brand initiatives. By providing these tools, DigitecPharma enables pharmacies to enhance their service offerings and adapt to the changing landscape of the pharmaceutical profession.
Kayentis
Venture Round in 2020
Kayentis is a global leader in electronic clinical outcome assessment (eCOA) and Decentralized Clinical Trial solutions, focused on enhancing the efficiency and quality of data collection in clinical trials for the pharmaceutical, biotech, and contract research organization sectors. Founded in 2005, the company has specialized in eCOA solutions across various phases of clinical development, addressing over 200 indications in more than 20 therapeutic areas. Kayentis has adapted to the evolving clinical research landscape by offering a comprehensive suite of services aimed at supporting science-driven and patient-centric approaches. With operational capabilities spanning the USA, Europe, and Asia, Kayentis provides a range of adaptable tools to streamline electronic data capture, simplifying the clinical trial process for both patients and research sites.
MediReport
Private Equity Round in 2020
MediReport is a software solutions provider focused on the healthcare sector, specifically for cardiovascular departments in clinics and hospitals. Founded in 1995 and based in Paris, France, the company develops a comprehensive data management platform designed to streamline the full patient care continuum in both invasive and non-invasive cardiology. Its flagship product, CardioReport, integrates various workflows and features, including imaging, reporting, hemodynamics, inventory management, registry integration, and analytics. By enhancing the working environment for cardiologists and healthcare professionals, MediReport aims to improve efficiency and patient outcomes in cardiovascular care.
Must Informatique
Acquisition in 2017
MUST Informatique is a French software company that specializes in providing solutions for service providers in the healthcare sector. The company develops operations management software tailored for home care and home health providers. Its software facilitates comprehensive management of commercial operations specific to home support services, including respiratory assistance, orthopedic needs, infusion, nutrition, and insulin therapy. By focusing on enhancing operational effectiveness and efficiency, MUST Informatique aims to improve the quality of care and services delivered to patients.
Kayentis
Venture Round in 2015
Kayentis is a global leader in electronic clinical outcome assessment (eCOA) and Decentralized Clinical Trial solutions, focused on enhancing the efficiency and quality of data collection in clinical trials for the pharmaceutical, biotech, and contract research organization sectors. Founded in 2005, the company has specialized in eCOA solutions across various phases of clinical development, addressing over 200 indications in more than 20 therapeutic areas. Kayentis has adapted to the evolving clinical research landscape by offering a comprehensive suite of services aimed at supporting science-driven and patient-centric approaches. With operational capabilities spanning the USA, Europe, and Asia, Kayentis provides a range of adaptable tools to streamline electronic data capture, simplifying the clinical trial process for both patients and research sites.